- Tytuł:
- Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
- Autorzy:
- Źródło:
- Nature Communications. 14(1)
Czasopismo naukowe